Trademarkia Logo

Australia

AU$
Trademark Search
NUCLEXIS

View On IPO.GOV.AU

NUCLEXIS
Cancelled: Cancelled at the request of IB

Last updated on 9 Jan 2021

Owner Info

Karyopharm Therapeutics Inc.

85 Wells Avenue

Newton MA 02459, UNITED STATES OF AMERICA

Serial Number

1922207 filed on 16 Jan 2018

Correspondent

Nicole Kinsley, Esq. Foley Hoag LLP

155 Seaport Boulevard,

Boston MA 02210-2600,

UNITED STATES OF AMERICA

NUCLEXIS

Classification Information

Class [005]
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation in humans and an Read More

Mark Details

Serial Number

1922207

Registered On

16 Jan 2018

Renewal On

NA

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
9th Jan 2021Status change to Voided
27th Nov 2018IP Right Registration Published
27th Nov 2018International Registration in Australia Protected correspondence sent
27th Nov 2018Status change to Registered/Protected
20th Sept 2018IP Right Acceptance Published
16th Sept 2018Clear Examination report approved
16th Sept 2018User Created Notice correspondence sent
16th Sept 2018Application Accepted correspondence sent
10th May 2018IP Right Filed Published
2th May 2018Application Status